V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195913 | 20125022 | 1.59 | 116.4 | Palliative (P) | null | 2021-01-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100035170 |
| 20195914 | 20125023 | 1.65 | 90.7 | Palliative (P) | 2017-12-13 | 2017-12-29 | Trastuzumab | 02 | N | TRASTUZUMAB | 101721393 |
| 20195919 | 20125024 | 1.5 | 60 | null | 2019-06-14 | 2019-07-05 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101774608 |
| 20195920 | 20125025 | 1.74 | 66.4 | Palliative (P) | null | 2017-03-17 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101478212 |
| 20195922 | 20125026 | 1.61 | 73.6 | Curative (C) | 2017-03-03 | 2017-03-03 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100547116 |
| 20195923 | 20125027 | 1.74 | 53 | null | 2020-01-30 | 2020-02-11 | Trastuzumab | 02 | null | TRASTUZUMAB | 101433427 |
| 20195926 | 20125028 | 1.65 | 74.2 | Palliative (P) | 2019-11-04 | 2019-11-15 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100427468 |
| 20195929 | 20125029 | 1.68 | 58 | Curative (C) | 2018-09-20 | 2019-08-18 | CETUXIMAB | 02 | N | CETUXIMAB | 100477621 |
| 20195932 | 20125030 | 1.65 | 76 | null | 2017-03-11 | 2017-03-11 | Trastuzumab | null | null | TRASTUZUMAB | 101351219 |
| 20195934 | 20125031 | 1.77 | 78.9 | null | 2020-01-28 | 2020-01-31 | Trastuzumab | 02 | null | TRASTUZUMAB | 101868176 |
| 20195936 | 20125032 | 1.88 | 107 | Palliative (P) | 2018-07-17 | 2018-08-07 | CETUXIMAB | 02 | N | CETUXIMAB | 101843870 |
| 20195943 | 20125033 | 1.73 | 75 | Adjuvant (A) | 2018-08-18 | 2019-03-06 | CETUXIMAB | 02 | N | CETUXIMAB | 100007941 |
| 20195945 | 20125034 | 1.63 | 63.4 | Palliative (P) | 2016-11-10 | 2017-11-25 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100736236 |
| 20195946 | 20125035 | 1.74 | 72 | Palliative (P) | 2016-12-20 | 2017-01-03 | Capecitabine + Cisplatin | N | null | CAPECITABINE + CISPLATIN | 100588433 |
| 20195950 | 20125036 | 1.77 | 72.1 | Neo-adjuvant (N) | 2016-07-25 | 2019-12-29 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101196076 |
| 20195952 | 20125037 | 1.76 | 50 | Palliative (P) | 2018-02-23 | 2018-03-02 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100031726 |
| 20195956 | 20125038 | 1.8 | 68.6 | Neo-adjuvant (N) | 2019-05-30 | 2019-06-28 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101359779 |
| 20195967 | 20125039 | 1.65 | 77.3 | Palliative (P) | 2017-02-09 | 2017-07-02 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101475914 |
| 20195969 | 20125040 | 1.74 | 73 | Curative (C) | 2013-11-05 | 2016-05-03 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101241730 |
| 20195970 | 20125041 | 1.73 | 67.7 | Adjuvant (A) | 2016-06-20 | 2016-07-06 | Trastuzumab | 02 | N | TRASTUZUMAB | 100405644 |
| 20195972 | 20125042 | 1.73 | 97.8 | Palliative (P) | 2016-06-08 | 2016-06-28 | CETUXIMAB | 02 | N | CETUXIMAB | 100522965 |
| 20195974 | 20125043 | 1.66 | 42.3 | Neo-adjuvant (N) | 2016-05-08 | 2016-06-01 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100771981 |
| 20195975 | 20125044 | 1.76 | 46.6 | Curative (C) | 2018-03-21 | 2018-03-28 | CETUXIMAB | 02 | null | CETUXIMAB | 100422000 |
| 20195976 | 20125045 | 1.75 | 62.6 | Palliative (P) | 2016-07-29 | 2016-08-14 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100615698 |
| 20195977 | 20125046 | 1.77 | 93.2 | Palliative (P) | 2016-03-24 | 2016-04-22 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101726030 |
| 20195981 | 20125047 | 1.56 | 64.8 | Neo-adjuvant (N) | 2020-01-03 | 2020-02-02 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100763944 |
| 20195982 | 20125048 | 1.65 | 53.2 | Adjuvant (A) | 2018-11-20 | 2018-11-25 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101764555 |
| 20195989 | 20125049 | 1.76 | 60 | Palliative (P) | 2019-03-13 | 2019-08-13 | CETUXIMAB | 02 | N | CETUXIMAB | 101711618 |
| 20195990 | 20125050 | 1.58 | 67.2 | null | 2016-08-08 | 2016-08-12 | Trastuzumab | null | null | TRASTUZUMAB | 100262836 |
| 20195992 | 20125051 | 1.7 | 76 | Palliative (P) | 2019-05-17 | 2019-05-24 | CETUXIMAB | 02 | N | CETUXIMAB | 101400412 |
| 20195993 | 20125052 | 1.81 | 84.4 | Palliative (P) | 2018-07-05 | 2019-08-17 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101861830 |
| 20195997 | 20125053 | 1.71 | 149.2 | Adjuvant (A) | 2016-10-16 | 2016-11-19 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101382867 |
| 20195999 | 20125054 | 1.57 | 124.2 | Palliative (P) | 2017-09-04 | 2017-09-04 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100423876 |
| 20196002 | 20125055 | 1.87 | 88.6 | Adjuvant (A) | 2017-03-20 | 2017-06-15 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101628935 |
| 20196003 | 20125056 | 1.77 | 118 | null | 2018-09-25 | 2018-10-10 | CETUXIMAB | 02 | null | CETUXIMAB | 100567560 |
| 20196005 | 20125057 | 1.9 | 64 | null | 2019-05-25 | 2019-06-02 | Trastuzumab | 02 | null | TRASTUZUMAB | 100477113 |
| 20196008 | 20125058 | 1.59 | 58.3 | null | 2019-03-19 | 2019-03-19 | Trastuzumab | 02 | N | TRASTUZUMAB | 101152284 |
| 20196019 | 20125059 | 1.8 | 58.4 | null | 2019-09-06 | 2019-09-29 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100495709 |
| 20196021 | 20125060 | 1.77 | 46.05 | null | 2018-06-18 | 2018-06-27 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101637850 |
| 20196025 | 20125061 | 1.49 | 114.6 | null | null | 2019-04-03 | Cetuximab 14 day | null | null | CETUXIMAB | 100045643 |
| 20196026 | 20125062 | 1.65 | 60 | null | 2016-08-12 | 2016-10-07 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 100122236 |
| 20196027 | 20125063 | 1.8 | 77.7 | Neo-adjuvant (N) | 2017-09-20 | 2017-10-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 101500360 |
| 20196031 | 20125064 | 1.77 | 102.5 | Palliative (P) | 2017-10-05 | 2019-03-27 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101086077 |
| 20196032 | 20125065 | 1.88 | 74.55 | Palliative (P) | 2017-09-03 | 2017-09-14 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101493710 |
| 20196033 | 20125066 | 1.74 | 86.5 | Palliative (P) | 2018-08-19 | 2018-09-03 | CETUXIMAB | 02 | N | CETUXIMAB | 101281037 |
| 20196034 | 20125067 | 1.75 | 90.6 | Adjuvant (A) | 2013-09-26 | 2018-09-18 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101473764 |
| 20196035 | 20125068 | 1.71 | 50.2 | Curative (C) | 2017-08-11 | 2017-08-25 | Cetuximab 14 day | 2 | N | CETUXIMAB | 101207308 |
| 20196037 | 20125069 | 1.96 | 73 | Neo-adjuvant (N) | 2020-01-03 | 2020-01-24 | Trastuzumab | 02 | N | TRASTUZUMAB | 100517554 |
| 20196038 | 20125070 | 1.74 | 75 | null | 2017-06-12 | 2017-07-21 | CETUXIMAB | 2 | null | CETUXIMAB | 100879334 |
| 20196040 | 20125071 | 1.8 | 70 | null | 2017-10-10 | 2017-10-14 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101835168 |